Tag: National Cancer Institute


Postdoc Wins Top Honors at National Cancer Institute’s Junior Investigator Meeting

|

Minjeong Kim, PhD, a postdoctoral fellow at the University of Tennessee Health Science Center, earned first place at the 2024 National Cancer Institute (NCI) Junior Investigator Annual Meeting for her podium talk focused on unraveling key genetic mutations in lung cancer. The meeting, held August 22 and 23 on the National Institutes of Health’s campus… Read More


Breast Cancer Research Team Pulls In $3 Million in National Support

|

UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on… Read More


Study Aims to Help People Lose Weight Using Everyday Technology

|

Researchers at the University of Tennessee Health Science Center are beginning a study exploring how interactive technology could help adults lose weight, especially those in underserved populations. Choosing Healthy Activities and Lifestyle Management through Portal Support (CHAMPS) is a research study sponsored by the National Cancer Institute and the National Institutes of Health. Karen Johnson,… Read More


UTHSC-Led Team Receives $5.2 Million for Study of Link Between Obesity, Cancer

|

The National Cancer Institute has awarded more than $5.2 million to a team lead by researchers from the University of Tennessee Health Science Center (UTHSC) for a study that will fill critical gaps in knowledge around obesity-mediated cancer risk. Liza Makowski, PhD, professor in the Division of Hematology and Oncology in the UTHSC College of… Read More


UTHSC-Led Team Receives $3.16 Million from National Cancer Institute for Cancer Immunotherapy Drug Development

|

A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in the Department of Physiology, is the lead investigator. Sue Chin Lee, PhD, associate professor in the… Read More